Tag: Access to Medicines

EB 144 IFPMA statement under agenda item 5.7, Access to Medicines and Vaccines Roadmap
68th WHO Regional Committee for Europe: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines
IFPMA Statement @EB 142 :Addressing the global shortage of, and access to, medicines and vaccines
IFPMA 2017 Interview Series: Experts take on 9th Asia Regulatory Conference
IFPMA Statement to New Essential Medicines List
IFPMA contribution to key global health discussions @WHA70 (22-31 May 2017)
WHO WHA 70 agenda item 13.3 Addressing the global shortage of, and access to, medicines and vaccines
Ensuring Essential Medicines Satisfy Priority Healthcare Needs of Populations
The Evolution of access to essential medicines for the treatment of HIV/AIDS
Access to medicines
Viral hepatitis
2015 IFPMA highlight of 4th African regulatory conference
L’Afrique a besoin de systèmes réglementaires plus efficaces afin d’améliorer l’accès aux médicaments
Pharmaceutical industry and global health
Addressing the gaps in global policy and research for non-communicable diseases
IFPMA facts & figures 2012
New report shows major increase in pharmaceutical research and development (R&D) for neglected diseases
Joint Industry Statement on Internet Sales and Access to Safe Medicines
The changing landscape on access to medicines
Study on access to essential HIV/AIDS treatments shows political will as most important factor
David Brennan World Health Day Talking Points
The pharmaceutical industry and global health: facts & figures
Evidence on access to essential medicines for the treatment of HIV/AIDS
Improving access to medicines for non-communicable diseases in the developing world
Voluntary licenses and non-assert declarations

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Code of Practice collaboration Counterfeit Medicines Counterfeits Developing World Donations Economic footprint Efficacy Ethics; Code; Business integrity; Compliance Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Geneva Pharma Forum IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem IP IVS Latin America Latin America Conference Malaria MDGs Medicines Mental and Neurological Disorders Millennium Development Goals NCD NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases NTDs Pandemic Influenza Pandemic preparedness partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention PSI Publications Public Health Quality R&D Regulatory regulatory systems Regulatory System Strengthening Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Vaccine Supply Value of Innovation Videos WHA WHO WIPO Women’s Cancers